Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

000766.SZ - Shenzhen - Healthcare - Drug Manufacturers - Specialty & Generic

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is headquartered in Tonghua, China.

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd trades as 000766.SZ on Shenzhen in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. Its latest stored price is $25.29 as of June 12, 2026.

Data updated June 12, 2026

Financial Snapshot